| |
| | AANS.org | Education and Meetings | AANS Scientific Journals | Neurosurgical Focus |
 | | Papaverine infusion also resulted in an initial decrease of TCD-measured velocities; however, reversal of vasospasm was transient in the majority of cases, rendering it much less effective as a treatment for vasospasm when used alone. |
 | | Whereas the use of papaverine must be tempered by its attendant risk of hemodynamic complications,[33] it remains potentially useful for the treatment of vasospastic vessel segments which cannot be treated with balloon dilation, such as the anterior cerebral artery, MCA branches, and distal distributions. |
 | | Reported complications of papaverine infusion include monocular blindness,[7] brainstem dysfunction (including respiratory arrest),[5,31] focal neurological deficits that resolved on cessation of papaverine infusion,[18,19] and formation of crystal emboli.[32] Moreover, as the present study indicates, papaverine infusion does not provide permanent reversal of vasospasm, thus requiring repeated infusions with the associated risks of repeated angiography. |
| aans.org /education/journal/neurosurgical/oct97/3-4-8.asp?... (4205 words) |
|